Download (CLEK) Study.

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Cataract wikipedia , lookup

Blast-related ocular trauma wikipedia , lookup

Human eye wikipedia , lookup

Visual impairment due to intracranial pressure wikipedia , lookup

Contact lens wikipedia , lookup

Cataract surgery wikipedia , lookup

Eyeglass prescription wikipedia , lookup

Keratoconus wikipedia , lookup

Transcript
Baseline Findings in the Collaborative Longitudinal
Evaluation of Keratoconus (CLEK) Study
Karla Zadnik, Joseph T. Barr, Timothy B. Edrington, Donald F. Everett, Mary Jameson,
Timothy T McMahon, Julie A. Shin, John L Sterling, Heidi Wagner, Mae O. Gordon, and
the Collaborative Longitudinal Evaluation oj Keratoconus (CLEK) Study Group
describe the baseline findings in patients enrolled in the Collaborative Longitudinal
Evaluation of Keratoconus (CLEK) Study.
PURPOSE. TO
METHODS. This
is a longitudinal observational study of 1209 patients with keratoconus enrolled at
16 clinical centers. Its main outcome measures are corneal scarring, visual acuity, keratometry, and
quality of life.
RESULTS. The CLEK Study patients had a mean age of 39-29 — 10.90 years with moderate to severe
disease, assessed by a keratometric-based criterion (95.4% of patients had steep keratometric
readings of at least 45 D) and relatively good visual acuity (77.9% had best corrected visual acuity
of at least 20/40 in both eyes). Sixty-five percent of the patients wore rigid gas-permeable contact
lens, and most of those (73%) reported that their lenses were comfortable. Only 13.5% of patients
reported a family history of keratoconus. None reported serious systemic diseases that had been
previously reported to be associated with keratoconvis. Many (53%) reported a history of atopy.
Fifty-three percent had corneal scarring in one or both eyes.
Baseline findings suggest that keratoconus is not associated with increased risk of
connective tissue disease and that most patients in the CLEK Study sample represent mild to
moderate keratoconus. Additional follow-up of at least 3 years will provide new information about
the progression of keratoconus, identify factors associated with progression, and assess its impact
on quality of life. {Invest Ophthalmol Vis Sci. 1998;39:2537-2546)
CONCLUSIONS.
T
he Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study is a multicenter observational study
supported by the National Eye Institute, Bethesda, Maryland. The purpose of the CLEK Study is to characterize prospectively the changes in vision, corneal curvature, corneal
status (i.e., corneal scarring), and quality of life in patients with
keratoconus and to determine the factors associated with these
changes across time. In this article, we summarize the study
design and baseline characteristics of patients enrolled in the
study.
From the College of Optometry, The Ohio State University, Columbus, Ohio (KZ and JTB), the Southern California College of Optometry, Fullerton, California (TBE and JAS), the National Eye Institute,
Bethesda, Maryland (DFE), the Pennsylvania College of Optometry,
Philadelphia, Pennsylvania (MJ), the University of Illinois-Chicago, Department of Ophthalmology, Chicago, Illinois (TTM), Gundersen Lutheran, LaCrosse, Wisconsin 0LS), Nova Southeastern University College
of Optometry (HW), and Washington University Medical School, Department of Ophthalmology & Visual Sciences and the Division of
Biostatistics, St. Louis, Missouri (MOG). A complete list of the CLEK
Study Group appears at the end of this article.
Supported by Grants U10-EY10419, U10-EY10069, and U10EY10077 from the National Eye Institute, National Institutes of Health,
Bethesda, Maryland; Conforma Contact Lenses, Norfolk, Virginia; Paragon Vision Sciences, CIBA Vision Corporation, Duluth, Georgia; and
the Ohio Lions Eye Research Foundation, Columbus, Ohio.
Submitted for publication February 24, 1998; revised June 30,
1998; accepted July 31, 1998.
Proprietary interest category: N.
Reprint requests: Karla Zadnik, The Ohio State University, College
of Optometry, 338 West Tenth Avenue, Columbus, OH 43210-1240.
Keratoconus is a progressive, asymmetric, noninflammatory disease of the cornea characterized by steepening and
distortion, apical thinning, and central scarring of the cornea.'
These corneal changes cause a mild to marked decrease in
vision secondary to high irregular astigmatism and frequently
to central corneal scarring. There are several characteristic
biomicroscopic corneal signs that become more prevalent as
the disease progresses.1'2 These include an inferiorly displaced,
thinned protrusion of the cornea, corneal thinning over the
apex of the cone, Vogt's3 striae in the posterior stroma, scars
in Bowman's layer, and Fleischer's ring, an either full or partial
ring of iron in the corneal epithelium at the base of the cone.
Although its cause is unknown, keratoconus has been putatively associated with atopic disease,4'5 eye rubbing,6'7 inheritance,8"12 and contact lens wear.13
Management varies with disease severity. Nonsurgical alternatives are used primarily in treating patients with keratoconus. Although the visual disturbances in keratoconus may be
managed with spectacles or hydrogel lenses early in the disease
process, rigid gas-permeable contact lenses are the treatment
of choice for the irregular astigmatism associated with the
disease.2 Occasionally, hydrogel lenses are used in later stages
in conjunction with rigid lenses in a piggyback lens design.
Patients are generally referred for penetrating keratoplasty
when they can no longer tolerate contact lenses or when
contact lenses provide inadequate vision. Poor vision with
contact lenses is often accompanied by apical corneal scarring,
but vision can be compromised even with optimal contact lens
correction and no corneal scarring. With concerted effort,
Investigative Ophthalmology & Visual Science, December 1998, Vol. 39, No. 13
Copyright © Association for Research in Vision and Ophthalmology
2537
Downloaded From: http://iovs.arvojournals.org/ on 05/05/2017
2538
Zadnik
most patients initially referred for corneal transplants can be
successfully refitted without surgery, yielding improved visual
acuity and increased contact lens wearing time.14"16
Previous, large-scale studies of keratoconus have been
focused on describing the disease's incidence and prevalence,17 on attempting to establish the disease's cause, 513 or
on trends in the clinical management of keratoconus. 51418 ' 9
Few have characterized the course of the disease and its associated factors in large samples of affected patients.20 With the
exception of our previous CLEK survey,2 all previous studies
have relied on retrospective evaluation of patients' medical
records. None of the previous studies has characterized the
interrelations among corneal curvature, biomicroscopic findings, and vision in keratoconus. Although visual function (other than visual acuity) has been described in small samples of
patients with keratoconus,2' none of the large-scale studies has
characterized vision and visual function beyond retrospective
Snellen visual acuity measurements recorded by an examining
clinician. No surveys of quality of life in keratoconus have been
performed. No data exist comparing patients' visual symptoms
with their clinically measured visual performance. None of the
attempts to stage and classify keratoconus has been performed
in a standardized manner.
The CLEK Study is a multicenter, prospective, observational study designed to describe the course of keratoconus
and to describe the associations among its visual and physiological manifestations. Over the course of 13 months, 1209
patients were enrolled at 16 clinics. Patients will be examined
annually for at least 3 years. Baseline and annual visit examinations include visual acuity (high- and low-contrast), patientreported quality of life, manifest refraction, keratometry, photodocumentation of the cornea, photodocumentation of the
patient's habitual rigid contact lenses, and photodocumentation of the flattest rigid contact lens from the CLEK Study trial
lens set to show apical clearance (the First Definite Apical
Clearance Lens [FDACL]). The CLEK Study's goal is to identify
risk factors that determine disease severity and progression in
keratoconus.
A specific purpose of the CLEK Study is to provide a
description of the distribution and rate of change in best
corrected high- and low-contrast visual acuity and corneal
curvature and to determine the proportion of patients with
incident corneal scarring and the proportion of patients requiring penetrating keratoplasty. Another specific purpose of this
study is to identify factors associated with changes over time in
visual acuity, corneal curvature, and corneal scarring.
MATERIALS AND METHODS
CLEK Study Design
The CLEK Study is a 16-center observational study of patients
with keratoconus, as described. The sample size goal was to
recruit at least 1000 patients, allowing for a 5% loss to follow-up in 3 years. In total, 1209 eligible patients were enrolled
between May 31, 1995, and June 29, 1996.
Training and Certification of Study Personnel
All examination procedures were performed by clinicians and
technicians who had completed training, who had successfully
demonstrated the ability to perform each measurement according to the protocol, and who had successfully completed writ-
Downloaded From: http://iovs.arvojournals.org/ on 05/05/2017
IOVS, December 1998, Vol. 39, No. 13
TABLE 1. Study Eligibility Criteria
Inclusion Criteria
Age
Irregular corneal surface
Slit lamp biomicroscopic
findings
Follow-up status
Exclusion Criteria
Surgical status
Other ocular disease
At least 12 years old
In either eye, identified by
distortion of the
keratometric mires,
scissoring of the
retinoscopic reflex, or
irregularity in the red
reflex observed with the
direct ophthalmoscope
Vogt's striae or a Fleischer's
ring of at least 2 mm arc
or corneal scarring
characteristic of
keratoconus in either eye
Able to complete at least 3
years of follow-up
No bilateral corneal
transplants
No nonkeratoconic ocular
disease in both eyes, that
is, no cataract,
intraocular lens implants,
macular disease, or optic
nerve disease other than
glaucoma (e.g., optic
neuritis, optic atrophy)
ten and verbal evaluations by the CLEK Study chairman's office. CLEK clinic personnel were trained and certified on nine
key tasks: study coordination, visual acuity measurement, refraction, keratometry, slit lamp biomicroscopy, corneal topography, corneal photography, fluorescein photography, and
contact lens verification.
Visit Schedule
Each CLEK clinic was expected to recruit 80 patients. Each
patient, whether an established patient at a clinic or an outside
referral patient, was screened for the entry criteria (Table 1).
After confirmation of eligibility, each patient was scheduled for
his or her baseline visit. Each patient will be seen annually for
a minimum of 3 years of follow-up (at least fovir visits). Investigators at each clinic obtained informed consent from their
patients. The CLEK Study protocol was approved by each
clinic's institutional review board, in accordance with the
tenets of the Declaration of Helsinki.
Patient-Completed Items
Each patient completed a patient background form and a Quality of Life Survey (SF-36) at baseline22; a patient history form
during the baseline visit and annually thereafter; and the National Eye Institute Visual Functioning Questionnaire,23 beginning at the first annual visit and annually thereafter. These
survey instruments collected data on the patient's ocular and
medical history, family history, history of contact lens wear,
and health-related and vision-related quality of life.
Interview
Questions about the patient's ocular general health and contact
lens history were answered in an interview format. These
IOVS, December 1998, Vol. 39, No. 13
included assessment of a family history of keratoconus, presence of systemic disease, eye rubbing, contact lens wearing
time, and contact lens comfort.
Examination
A detailed examination was performed on each eligible patient.
Distance visual acuity was measured using the high- and low(Michelson contrast 10%) contrast Bailey-Lovie24 chart (School
of Optometry, University of California, Berkeley). The chart is
located at 4 m, and the white background of the chart has a
standard luminance, calibrated weekly. If the patient could not
correctly identify all five of the letters on the top line of the
Bailey-Lovie chart at 4 m, the patient was moved forward to a
1-m test distance.
Visual acuity was measured in three ways: entrance visual
acuity, high- and low-contrast with habitual correction in each
eye and then in both eyes; best corrected visual acuity, highand low-contrast with best correction (in rigid contact lens
wearers, their rigid contact lenses with optimal overrefraction;
in those patients who do not wear rigid contact lenses, a CLEK
Study trial contact lens with base curve radius equal to the
steep keratometric reading plus optimal overrefraction) in
each eye; and manifest refraction visual acuity, high contrast
Bailey-Lovie visual acuity with manifest refraction in each eye.
Patients read the chart beginning at the top during each measure until they missed at least three letters on a line on which
they attempted to read every letter. Visual acuity scores were
recorded as the number of letters read correctly.
Manifest refraction was performed according to standard
subjective techniques with additional methods—for example,
larger steps between subjective lens choices, higher power
Jackson crossed cylinder, and subjective cylinder axis adjustment, tailored to patients with poorer vision. The same technique was used to perform overrefractions over the patient's
habitual contact lenses or trial lenses from the CLEK Study trial
lens set.
Fluorescein patterns of habitual contact lenses were assessed. Fluorescein was instilled, and the contact lensfitwas
observed by slit lamp biomicroscopy with cobalt and Wratten
12 (or Tiffen yellow) filters in place. A grading system using
photographic standards specifying the centralfluoresceinpattern as definite touch, touch, clearance, or definite clearance
for each observation was used. Peripheral clearance was
graded as minimum-unacceptable, minimum-acceptable, average, maximum-acceptable, or excessive-bubbles.
Keratometry was performed by taking two readings in the
flattest and steepest meridians, which may or may not be 90°
apart. The keratometer was calibrated to steel balls of known
curvature weekly. Keratometry range was extended with the
use of auxiliary lenses (+1.25 D or +2.25 D) to a maximum
curvature of 68.30 D,25 as necessary.
Slit lamp biomicroscopy was performed according to a
standardized protocol and included examination of the adnexa,
conjunctiva, and cornea (for epithelial staining and corneal
scarring). Graded observations included limbic injection, bulbar injection, conjunctival follicles and papillae, and epithelial
and stromal corneal edema. The presence or absence of a
contact lens-induced epithelial imprint, neovascularization,
Vogt's striae, Fleischer's ring, and any other corneal abnormalities, such as nonkeratoconic scars, was recorded. Corneal
scarring was scored as definitely not scarred, probably not
scarred, probably scarred, or definitely scarred and was graded
Downloaded From: http://iovs.arvojournals.org/ on 05/05/2017
CLEK Study Baseline
2539
for size, density, and location. Staining of the corneal epithelium with fluorescein was recorded as definitely not present,
probably not present, probably present, or definitely present.
Location and pattern of the stain (arc, punctate, foreign body,
swirl, dimple veiling, coalesced, and full-thickness epithelial
defect) were recorded.
A protocol for determining the FDACL to provide a measure of corneal curvature was developed specifically for the
CLEK Study.26 A rigid contact lens from the CLEK Study trial
lens set with a base curve radius equal to the steep keratometric reading was applied. If the initial trial lens was judged to be
flat centrally, a steeper trial lens was applied to the eye for
fluorescein pattern evaluation. This procedure was repeated
until an apical clearance pattern was achieved. Therefore, the
objective of the contact lens fitting procedure was tofindthe
flattest lens in the trial lens set that exhibited a definite apical
clearance fluorescein pattern so that the sagittal depth of the
base curve chord diameter was greater than the sagittal depth
of the cornea, when using the same chord diameter. If the
initial trial lens was judged to be steep centrally, a flatter trial
lens was applied to the cornea forfluoresceinpattern evaluation. This procedure was repeated until apical touch was observed. The FDACL protocol was not performed on grafted
eyes. The CLEK Study trial lens set's base curve radii were
measured monthly to ensure that the lenses are in the proper
order and that none of the lenses were warped. The fluorescein pattern of the FDACL and the lens with base curve radius
0.2 mm flatter were photographed. Exposed but undeveloped
film was mailed to the CLEK Photography Reading Center for
centralized development, labeling, and grading. Rigid contact
lens parameters were measured. Parameters measured included base curve radius, contact lens power, overall diameter,
optic zone diameter, and center thickness.
Videokeratography was performed at each clinic using
the instrument available to the respective clinic. Eight clinics have TMS-1 devices (Tomey Technology, Cambridge,
MA) units, four of the clinics have EyeSys units (EyeSys
Premier, Irvine, CA) units, two of the clinics have Visioptic
EH270 (Alcon Surgical, Fort Worth, TX) units, and one clinic
has a Humphrey Mastervue (Humphrey Instruments, San
Leandro, CA) unit. At the time of the grant submission and
start of the study, a recognized method for analyzing corneal
topography data was not apparent; therefore, a large expenditure to equip each site with the same instrument was
impractical. Study investigators opted to collect corneal
topography data with the existing instrument at each site
with the intent of analyzing these data later. It was recognized early that developing a method for pooling data from
a variety of instruments would be a challenge. Strategies are
in development for analyzing these data.
Four central parallelepiped photographs of the central
cornea were taken, and the CLEK standardized corneal photography protocol was used to document the presence or
absence of corneal scarring. After pupillary dilation, two
oblique photographs were taken of the entire cornea. Exposed
but undeveloped film was mailed to the CLEK Photography
Reading Center at The Ohio State University College of Optometry, Columbus, for centralized development, labeling, and
grading. Dilated fundus examination was performed, and intraocular pressure was measured at each visit.
2540
Zadnik
IOVS, December 1998, Vol. 39, No. 13
TABLE 2. Power
for Detecting Risk Factors
Percentage
with Risk
Factor
PI = 0.10
P2 = 0.18
PI = 0.15
P2 = 0.26
PI = 0.20
P2 = 0.33
PI = 0.25
P2 = 0.40
15
20
25
0.748
0.838
0.890
0.873
0.935
0.964
0.918
0.963
0.982
0.953
0.983
0.993
Total sample size, 1000. Odds ratio of >2.00.
PI, the probability of the event in the group without the risk factor; P2, the probability of the event
in the group with the risk factor.34
Statistical Methods: Sample Size Rationale
RESULTS
The minimum overall target sample of 1000 was selected to
provide adequately narrow 95% confidence intervals for estimates of means (e.g., keratometry, visual acuity, quality of life)
and proportions (e.g., corneal scarring) of the primary outcome variables. A sample size of 1000 patients provides reasonable power for detecting risk factors for events of relatively
low incidence, such as central corneal scarring (Table 2). A
sample of 1000 patients provides sufficient power to detect
risk factors that explain 10% of the variation in continuous
variables such as keratometry, visual acuity, and quality of
life.27
One thousand two hundred nine patients were enrolled in the
CLEK Study (Fig. 1). By self-report, 829 (68.5%) of the patients
were white, 240 (199%) were black, 99 (8.2%) were Hispanic,
and 41 (3-4%) were a mix of other ethnic categories. Men
comprised 55.9% of the sample. The age distribution of the
patients is shown in Figure 2 (mean age, 39-29 ± 10.90 years
[SD]). One hundred eighteen of the patients (98%) entered the
CLEK Study having undergone a penetrating keratoplasty in
one eye before the baseline visit (54 in the right eye and 64 in
the left eye). The educational level of the CLEK Study patients
is shown in Table 3. Eighty percent of the patients had at least
some college education.
The mode of visual correction in the patients is shown in
Tables 4 and 5. Most of the patients' vision was corrected with
contact lenses in both eyes (892 [74%] of 1209); of these, 571
(64%) of 892 also used glasses in some capacity (Table 6). A
small proportion of patients (3-6%) used no visual correction in
either eye at baseline. Seven hundred ninety (65%) patients
wore rigid contact lenses in both eyes, and 94 (8%) wore rigid
contact lenses in one eye (Table 5).
The patients responded to various questions designed to
assess the burden of having keratoconus. Only 15 (1.4%) of
1096 patients at baseline reported having changed jobs because of keratoconus, and only 23 (2.1%) of 1073 received
keratoconus-related disability, but 124 (11.5%) of 1080 patients
120
100c
CD
80-
to
CL
60-
CD
13
4020-
400
Participating Clinic
FIGURE 1.
Distribution of the 1209 enrolled study patients by
participating clinic. UAB, University of Alabama at Birmingham
School of Optometry; UCB, University of California, Berkeley
School of Optometry; UHC, University Hospitals of Cleveland;
Nova, Nova Southeastern University; Gun, Gundersen Lutheran; IN, Indiana University School of Optometry; IL, University of Illinois at Chicago Department of Ophthalmology;
UCLA, Jules Stein Eye Institute, University of California, Los
Angeles; UMSL, University of Missouri-St. Louis School of Optometry; NE, Northeastern Eye Institute; OSU, The Ohio State
University College of Optometry; PCO, Pennsylvania College of
Optometry; SCCO, Southern California College of Optometry;
UT, University of Texas at San Antonio Health Science Center;
UUT, University of Utah; SUNY, State University of New York
College of Optometry.
Downloaded From: http://iovs.arvojournals.org/ on 05/05/2017
<30
FIGURE 2.
study.
30-39
40-49
50-59
Age (years)
>60
Age distribution of the 1209 patients enrolled in the
CLEK Study Baseline
IOVS, December 1998, Vol. 39, No. 13
TABLE 3. Educational Level (by Patient Self-Report) of
Enrolled Study Patients at Baseline
Education
Less than 11 years
High school or equivalency
diploma
Some college
Completed college
Some graduate school
Number of
Patients
Percentage
of Sample
46
3.8
192
348
287
336
15.9
28.8
23.7
27.8
reported missing work because of keratoconus. One hundred
(10.1%) of 988 contact lens-wearing patients reported that
they were unable to wear their contact lenses for leisure
activities, and 174 (17.6%) of 986 contact lens-wearing patients reported that they could not wear their contact lenses to
read at night. Six hundred forty-one (35 1%) of 988 contact
lens-wearing patients reported a refitting of their contact
lenses in the year before their baseline visit.
Patients were asked whether they rubbed their eyes vigorously, and they were allowed to answer the question for
each eye. Of the 1207 patients who responded to the eye
rubbing question, 582 patients (48.2%) reported rubbing both
eyes vigorously, whereas only 27 patients (2.2%) reported
rubbing only one eye vigorously. Five hundred fifty-nine patients (46.3%) reported that they rubbed neither eye. Thirtynine patients (32%) were unsure whether they rubbed their
eyes.
No patient reported a history of Down syndrome, Marfan
syndrome, focal dermal hypoplasia, Ehlers-Danlos syndrome,
infantile tapetoretinal degeneration, oculodentodigital syndrome, osteogenesis imperfecta, or Rieger's anomaly. Six hundred thirty-nine patients (52.9%) had hay fever or allergies, 180
(14.9%) had asthma, and 101 (8.4%) had atopic dermatitis.
Cardiovascular disease was present in 74 patients (6.1%), diabetes mellitus in 23 (1.9%), and cystic fibrosis in 2 (0.16%).
4. Type of Visual Correction Worn by Study
Patients at Baseline
TABLE
Type of Correction
Same in both eyes
Unaided
Glasses
Contact lenses
Glasses and contact lenses
Different in each eye
One eye: Unaided
Fellow eye: Contact lenses
One eye: Glasses and contact
lenses
Fellow eye
Unaided
Contact lenses
Glasses
Total
Number of
Patients
Percentage
of Patients
43
194
321
571
16.1
26.6
47.2
37
3.1
2
1
40
1209
Downloaded From: http://iovs.arvojournals.org/ on 05/05/2017
3.6
0.2
0.1
3.6
100
2541
TABLE 5. Patients Wearing Specific Types of Contact
Lenses at Baseline
Type of Correction
Rigid contact lenses*
Soft contact lenses
Piggyback contact lenses
Hybrid (Softperm)
One Eye
Two Eyes
94(8)
790 (65)
30(2)
17(1)
24(2)
21(2)
18(1)
17(1)
Eyes may be represented more than once if patient wears more
than one type of contact lens in an eye.
Values are number of patients with corrective lenses, with percentage in parentheses.
* lligid gas-permeable contact lenses or conventional hard polymethylmethacrylate contact lenses.
Of the 896 patients in whom contact lens comfort was
assessed at baseline, 652 (72.8%) reported that their contact
lenses were comfortable in both eyes. Ninety-six patients
(10.7%) reported that contact lenses were irritating in both
eyes, and 147 patients (16.4%) reported that one lens was
comfortable and the other irritating. One hundred sixty-three
patients (135%) reported a family history of keratoconus in a
parent, sibling, child, aunt, or uncle.
High-contrast entrance visual acuity and best corrected
visual acuity for the better eye are summarized in Table 6.
Ninety percent of the patients had entrance acuity of 20/40 or
better, and 95.5% had best corrected acuity of 20/40 or better.
Monocular entrance visual acuity results by better eye and
worse eye are shown in Table 7. Forty-five percent of patients
had similar entrance visual acuity in both eyes. Sixty-three
percent had entrance visual acuity of 20/40 or better in both
eyes.
The best corrected high-contrast monocular visual acuity
data by better and worse eye are shown in Table 8. Approximately one-half of the patients had equal visual acuity in both
eyes. Compared with the entrance visual acuity, a higher proportion of patients achieved at least 20/20 best corrected visual
acuity in both eyes. A small proportion of patients had best
corrected visual acuity worse than 20/60 in either eye. The
subjective refraction yielded sphere results of —5.04 ± 1.84 D
and cylinder results of —2.49 ± 1.84 D (randomly selected, one
eye per person; n = 1205).
Disease severity by central keratometry is depicted in
Table 9. As expected, the flat keratometric reading was steeper
with more severe disease, and the magnitude of corneal toric6. High-Contrast Entrance and Best Corrected
Monocular Visual Acuity in Study Patients at Baseline
TABLE
Snellen Visual
Acuity, Better
Eye
20/20 or better
20/21 to 20/40
20/41 to 20/69
20/70 to 20/199
20/200 or worse
Total
Entrance
High-Contrast
Visual Acuity
Best Corrected
High-Contrast
Visual Acuity
409 (33.9)
693 (57.4)
84 (7.0)
18(1.5)
4 (0.3)
1208 (100)
538 (44.7)
612 (50.8)
43 (3.6)
10 (0.8)
1 (0.1)
1204 (100)
Patients are classified by visual acuity of the better eye.
Values are number of patients, with percentage in parentheses.
2542
Zadnik
IOVS, December 1998, Vol.39, No. 13
TABLE 7. Entrance High-Contrast Monocular Visual Acuity for 1208 Study Patients at Baseline
Snellen Visual Acuity, Worse eye
Snellen Visual
Acuity, Better Eye
20/20
or better
20/21 to
20/40
20/41 to
20/69
20/70 to
20/199
20/200
or worse
20/20 or better
20/21 to 20/40
20/41 to 20/69
20/70 to 20/199
20/200 or worse
65 (5.4)*
278 (23.0)
418 (34.6)*
35 (2.9)
178 (14.7)
40 (3.3)*
19(1.6)
64 (5.3)
29 (2.4)
12(1.0)*
12(1.0)
33 (2.7)
15(1.2)
6 (0.5)
4 (0.3)
Each table entry represents the number of patients classified by the visual acuity level in each eye, with the percentage of patients in
parentheses.
* Equal acuity in both eyes. Empty cells are logically impossible.
ity was greater with more severe disease. A profile of disease
severity in the CLEK Study sample was also developed (see
Table 11) that is distinctly skewed in the direction of moderate
to severe disease, when measured by the steep keratometric
reading.
When corneal curvature was assessed by the base curve
radius of the flattest contact lens that vaulted the cornea
(FDACL), the mean base curve radius of the FDACL was
50.94 ± 5.70 D for the 1182 patients for whom this assessment
was made. The correlation of FDACL with the steep keratometric reading was 0.89 (Pearson correlation; P = 0.001).
The slit lamp biomicroscopic signs of keratoconus (Vogt's
striae, Fleischer's ring, and corneal scarring) are listed in Table
10. Although the majority of patients had a Fleischer's ring in
both eyes, the presence of Vogt's striae was noted in both eyes
of only one-third of the patients. One half of the patients
entered the study with no corneal scarring in either eye.
DISCUSSION
The 1209 patients with keratoconus enrolled in the CLEK
Study represent the most systematically studied and carefully
characterized sample of patients with keratoconus ever prospectively examined. Previous samples have been studied retrospectively,2'5' '3.17-20,28-30 b u t because of the rarity of the
disease,17 all studies, including ours, were clinic-based (Table
11). In contrast to previous studies, the CLEK Study patientbased entry criteria were rigorously adhered to by the CLEK
clinic personnel. The requirement that each patient have a slit
TABLE
lamp biomicroscopic sign of keratoconus (Vogt's striae, Fleischer's ring of at least 2 mm of arc, or corneal scarring characteristic of keratoconus in at least one eye) resulted in a
sample with some fellow eyes that could be classified as exhibiting early or preclinical keratoconus. Conversely, some
patients had moderate or advanced keratoconus in one eye and
had had a penetrating keratoplasty in the fellow eye. The result
of these carefully applied entry criteria is a large sample of
patients whose disease encompasses the entire spectrum of
the disease that we clinically label as keratoconus.
The CLEK Study patients represent a highly educated
sample. We postulate this may be because of selection bias.
Volunteers for studies are typically more educated,31'32 and
many of our clinics are in academic settings. Our ethnic distribution approximates that of the United States population. The
age distribution of the CLEK Study patients is distinctly skewed
toward younger ages, similar to those in other studies (Fig. 2).
This may be because of several factors, including study exclusion criteria, but the age pattern is counter-intuitive because
keratoconus is a chronic disease. Thus, a larger proportion of
older people with the disease would have been expected in
the sample. One prospective study found no increased mortality associated with keratoconus.17 Perhaps older patients with
keratoconus are not as dependent on contact lens wear, have
undergone bilateral penetrating keratoplasty, or do not receive
routine eye care at our 16 clinics.
Most of the patients enrolled in the CLEK Study wore rigid
gas-permeable contact lenses. These data parallel those of our
preliminary CLEK survey, which showed that vision in 75% of die
8. Best Corrected High-Contrast Monocular Visual Acuity for 1204 Study Patients at Baseline
Snellen Visual Acuity, Worse Eye
Snellen Visual
Acuity, Better Eye
20/20 or better
20/21 to 20/40
20/41 to 20/69
20/70 to 20/199
20/200 or worse
20/20 or
better
169 (14.0)*
20/21 to
20/40
20/41 to
20/69
20/70 to
20/199
20/200
or worse
331 (27.5)
438 (36.4)
27 (2.2)
128 (10.6)
28 (2.3)*
8 (0.7)
39 (3.2)
14(1.2)
10 (0.8)*
3 (0.3)
7 (0.6)
1 (0.1)
0(0)
1 (0.1)*
Each table entry represents the number of patients classified by the visual acuity level in each eye, with the percentage of patients in
parentheses.
* Equal acuity in both eyes. Empty cells are logically impossible.
Downloaded From: http://iovs.arvojournals.org/ on 05/05/2017
CLEK Study Baseline
IOVS, December 1998, Vol. 39, No. 13
2543
9. Flat Keratometric Reading and Corneal Toricity for Three Categories of
Steep Keratometric Reading
TABLE
Steep Keratometric
Reading
Mild (<45 D)
Moderate (45-52 D)
Severe (>52 D)
Overall
Number of
Patients*
55 (4.6)
586 (48.7)
562 (46.7)
1203 (100.0)
Flat Keratometric
Reading (D)f
42.48 ±
45.73 ±
53.87 ±
49.49 ±
1.09
2.44
5.70
6.01
Corneal
Toricityf
1.41
3.28
4.01
3.53
±
±
±
±
1.06
2.23
3.45
2.87
All values are for the worse, or more advanced eye, as categorized by the steep keratometric reading.
Based on 1203 patients for whom flat and steep keratometric readings are available at baseline.
* Values in parentheses are percentages.
f
Values are means ± SD.
patients was corrected with rigid contact lenses2 and agrees with
data collected by other investigators.1319 Some previous reports
do not document the proportion of patients corrected with contact lenses.1718 Some reports of small samples suggest approximately equal numbers of patients treated with either contact
lenses or surgery.2830 Previous studies have shown that patients
classified as surgical candidates could be fitted with rigid gaspermeable contact lenses when an additional contact lens refit
was attempted before surgery.14"16 Large variability in reports of
contact lens correction among patients with keratoconus may
reflect unique features of patient samples associated with given
investigators or institutions.
In evaluating contact lens comfort, the majority of CLEK
Study patients reported their lenses to be comfortable. However, 10% to 18% of them could not wear their lenses adequately during leisure activities or when reading at the end of
the day. Perhaps the patients reported on the comfort at the
time of the question (i.e., during the study visit) and may not
have assessed comfort based on the duration of lens wear
throughout a given day or during several days.
Our patient-reported findings on spectacle correction
show, however, the value of spectacles as an adjunct to contact lens wear. Patients may benefit from spectacles fitted to
wear over their rigid contact lenses to eliminate uncorrected
astigmatism, or they may benefit from bifocals or reading
glasses for presbyopia. Many patients reported possession of
spectacles as back-up to their contact lenses, presumably for
use when they were unable to tolerate their contact lenses-for
example, on awakening or at night.
10. Slit Lamp Biomicroscopic Signs of
Keratoconus Reported by Examining Clinician
at Baseline
Slit Lamp
Biomicroscopic
Sign
Vogt's striae
Fleischer's ring
Corneal scarring
Corneal irregularity*
Number of Involved Eyes per
Patient
0
427 (35)
169 (14)
569 (47)
3(0.3)
418 (35)
364 (30)
377 (31)
154(13)
364 (30)
676 (56)
263 (22)
1052(87)
Values are number of patients examined who showed each sign;
percentage in parentheses. Total patients examined, 1209* Irregular keratometric mires or irregular retinoscopic reflex.
Downloaded From: http://iovs.arvojournals.org/ on 05/05/2017
The association between eye nibbing and keratoconus
dates back many years.6 A problem with documenting this
association and its magnitude is the definition of an appropriate comparison group. For example, no comparison between
rigid contact lens-wearing patients with and without keratoconus has ever been conducted.
Most clinicians associate atopic disease with keratoconus.
They expect affected patients to exhibit the signs and symptoms of hay fever, allergy, asthma, and atopic dermatitis more
frequently than the general population. A reasonable estimate
for the prevalence of atopy in the general population is 10% to
20%.33 Obviously, this estimate is geography- and sample-dependent. Previous reports of the prevalence of atopy in patients with keratoconus have ranged from 24%19 to 42%5 to a
high of 53%.18 Our highest estimate is 53% for hay fever and
allergies and is in keeping with estimates in these reports. The
clinical significance of this association is unknown. Perhaps
patients with keratoconus who also have atopic disease are
especially prone to eye rubbing, simply because their eyes itch,
and eye nibbing is associated with but not causative of keratoconus.
Previous case reports or small case series of patients with
rare systemic diseases and keratoconus1 were not confirmed
by the CLEK Study sample. It may be that anywhere from
none17 to a small proportion of patients with keratoconus also
have connective tissue disorders,18 but such disorders are
certainly not present in the majority of patients.
Reported rates of a positive family history of keratoconus
are in the range of 6% to 8% 121718 with one study reporting
15%,28 compared with our report of 135%. One study of the
corneal topography of 28 family members of 5 patients with
keratoconus showed an increased prevalence of abnormal but
nonkeratoconic corneal topography, suggesting an inheritance
pattern with variable penetrance in some cases of the disease.8
Visual acuity in the CLEK Study patients is relatively good.
Comparison of our data on entrance with that of best corrected
visual acuity shows that the CLEK Study patients have the
potential of seeing better than they do with their habitual
visual correction. These results may lead eye care practitioners
to evaluate their patients' current mode of correction more
critically and to attempt to improve visual acuity.
The CLEK Study patients are classified overwhelmingly
into the steep keratometric reading-based categories of moderate and severe. Twenty-one percent of Ihalainen's much
smaller sample of patients with keratoconus had steep keratometric readings 52.00 D or steeper28 compared with 47% of
2544
TABLE
Zadnik
IOVS, December 1998, Vol. 39, No. 13
11. Summary of Previous Epidemiologic Studies of Patients with Keratoconus
Study
Source of
Patients
Number of
Eyes/Patients
102/64
Kennedy et
al., 198617
Macsai et al.,
1990' 3
Mayo Clinic
Cornea specialty
practice
398/199
Eggink et al.,
198820
Academic and
nonacademic
clinical
centers
Three cornea
specialty
practices
??/874
Lass et al.,
199019
Disease Severity
Method of
Severity
Characterization
Diagnostic criteria
only
Mild (55%); moderate
(41%); severe (4%)
Not applicable
Not given
Not applicable
834/417
No categorical
designations
Categories by best
corrected visual
acuity and
average
keratometric
reading
Not applicable
Spectacle-corrected
visual acuity
Swann and
Waldron,
1986 5
Private
optometry
practice
87/57
No discussion
lhalainen,
198628
University
hospital
??/212
Degrees I through IV
Steep keratometric
reading
categories
Crews et al.,
199430
Cornea and
contact lens
specialty
practice
118/66
Categorization by
type of
management only
Mean keratometric
reading
Tuft et al.,
1994 18
Specialty
contact lens
clinic
5242/2723
Presented only in
context of surgical
intervention
Zadnik et al.,
19962
38 clinical
centers
2379/1579
No categorical
designations
Presented only in
context of
surgical
intervention
Categories by bestcorrected visual
acuity and
average
keratometric
reading
Age
Distribution
Age at diagnosis
only
Mean *» early
30s; no one
older than 56
years
Age at diagnosis
only
Mean, 35 ± 11
years; 90%
^50 years of
age
Mean, 28.5
years;
distribution
unknown
Mean, 27.7 ±
10.6 years;
92% <50
years of age
Mean, 28 years;
range, 10-83
years;
distribution
unknown
Age at diagnosis
only
Mean, 37 years;
range, 10-89
years; 88% <
50 years of
age
??, number of eyes not specified.
the CLEK Study sample. Corneal toricity, when measured by
keratometry, increases dramatically with increasing keratometric-defined disease severity, indicating that patients with more
advanced keratoconus have not only steeper corneas but also
more toric corneas. Perhaps the limitations on visual acuity and
the ability to fit contact lenses in severe keratoconus are the
result of this combination of corneal steepness, corneal toricity, and corneal irregularity.
Similar to our previous report,2 many patients exhibited
the slit lamp biomicroscopic signs of keratoconus. Almost one
quarter of the CLEK Study sample patients have corneal scarring in both eyes, but almost one-half of them do not have
corneal scarring in either eye. From these latter patients, and
the 377 patients with scarring in only one eye, we expect to
describe the annual incidence of corneal scarring in keratoconus and to describe risk factors associated with the development of new scarring.
Downloaded From: http://iovs.arvojournals.org/ on 05/05/2017
This represents the baseline results from the Collaborative Longitudinal Evaluation of Keratoconus (CLEK)
Study. The patients are young with moderate to severe
disease by a keratometric-based criterion, with good visual acuity. They are predominantly rigid gas-permeable
contact lens wearers whose lenses are mostly comfortable. Few of them report a positive family history of keratoconus. None of them report the serious systemic diseases that have been associated with keratoconus, and
many of them report a history of atopy. Many of them
exhibit the slit lamp biomicroscopic signs of keratoconus,
but most of them have at least one cornea in which corneal
scarring has not developed. This cohort of 1209 patients
spans the spectrum of keratoconus and will be observed
for a period of at least 3 years to develop a picture of
the progression of keratoconus and risk factors associated
with progression of the disease.
CLEK Study Baseline
IOVS, December 1998, Vol. 39, No. 13
Acknowledgments
The CLEK Study Group (as of May 1998)
Clinical Centers
University of Alabama at Birmingham School of Optometry,
Birmingham: William "Joe" Benjamin (Principal Investigator),
C. Denise Pensyl (Coinvestigator), Carol Rosenstiel (Coinvestigator), Maria S. Voce (Study Coordinator); Brian Marshall (Coinvestigator, 1994 -1995).
Berkeley School of Optometry, University of California:
Nina E. Friedman (Principal Investigator), Dennis S. Burger
(Coinvestigator), Pamela Qualley (Study Coordinator), Karla
Zadnik (Principal Investigator, 1994-1996).
Department of Ophthalmology, University Hospitals of
Cleveland and Case Western Reserve University, Ohio: Loretta
B. Szczotka (Principal investigator), Jonathan H. Lass (Coinvestigator), Beth Ann Benetz (Photographer), Kimberly D. Supp
(Technician), Laura A. Teutsch (Technician), Stephanie Schach
(Study Coordinator), Bonita Darby (Study Coordinator, 19941996), Ellen M. Stewart (Photographer, 1995-1997).
Gundersen Lutheran, La Crosse, Wisconsin: John L. Sterling (Principal Investigator), Thomas M. Edwards (Coinvestigator), John D. Larson (Coinvestigator), Eric M. Sheahan (Photographer), John M. Sake (Photographer), Lorna J. Plenge
(Technician), Janet M. Hess (Study Coordinator-Technician),
Jill A. Nelson (Study Coordinator-Technician).
University of Illinois at Chicago Department of Ophthalmology: Timothy T. McMahon (Principal Investigator), S. Barry
Eiden (Coinvestigator), Jamie L. Putz (Study Coordinator), Tim
Ehrecke (Photographer, 1994-1995), Mildred Santana (Technician, 1997).
Indiana University School of Optometry, Bloomington,
and Indianapolis Eye Care Center: Gerald E. Lowther (Principal
Investigator), Carolyn G. Begley (Coinvestigator), Donna K.
Carter (Study Coordinator-Technician), Nikole L. Himebaugh
(Optometrist), Lee M. Wagoner (Study Coordinator).
Jules Stein Eye Institute, University of California Los Angeles: Barry A. Weissman (Principal Investigator), Lisa A. Barnhart (Coinvestigator), Melissa W. Chun (Coinvestigator), Ronit
Englanoff (Coinvestigator), Louis Rosenberg (Coinvestigator),
Elisabeth T. Lim (Technician), Lilian L. Andaya (Study Coordinator).
St. Louis School of Optometry, University of Missouri:
Larry J. Davis (Principal Investigator), Edward S. Bennett, (Coinvestigator), Beth A. Henderson (Coinvestigator), Amber A.
Reeves (Study Coordinator), Nancy M. Duquette (Back-up
Study Coordinator).
State College of Optometry, State University of New York,
New York: David P. Libassi (Principal Investigator), Ralph E.
Gundel (Coinvestigator).
Northeastern Eye Institute, Scranton, Pennsylvania: Joseph
P. Shovlin (Principal Investigator), John W. Boyle (Coinvestigator), Stephen C. Gushue (Photographer), Cheryl Haefele (Study
Coordinator), Stephen E. Pascucci, (Medical Monitor).
Nova Southeastern University College of Optometry, Ft.
Lauderdale, Florida: Heidi Wagner (Principal Investigator), Andrea M. Janoff (Coinvestigator), Chris Woodruff (Photographer), Arnie Patrick (Study Coordinator), Julie A. Tyler (Backup Coordinator), Karla E. Rumsey (Coinvestigator, 1995).
The Ohio State University College of Optometry, Columbus: Barbara A. Fink (Principal Investigator), Jason Nichols
(Study Coordinator), Skyla A. Burns (Study Coordinator), Susan
Downloaded From: http://iovs.arvojournals.org/ on 05/05/2017
2545
L. Sabers (Study Coordinator, 1994-1996), Lisa Badowski (Coinvestigator, 1995-1996).
Pennsylvania College of Optometry, Philadelphia: Joel A.
Silbert (Principal Investigator), Kenneth M. Daniels (Coinvestigator), David T. Gubman, (Coinvestigator), Mary Jameson
(Study Coordinator).
Southern California College of Optometry, Fullerton: Timothy B. Edrington (Principal Investigator), Julie A. Shin (Coinvestigator), Julie A. Schornack, (Coinvestigator).
John Moran Eye Center, Department of Ophthalmology,
University of Utah, Salt Lake City: Harald E. Olafsson (Principal
Investigator), Libbi A. Tracy (Coinvestigator), Paula F. Morris
(Photographer), Doug M. Blanchard (Photographer), Marie Cason (Technician), Lizbeth A. Malmquist (Technician), Kate M.
Landro (Study Coordinator), Deborah Y. Harrison (Study Coordinator).
Former Clinical Center
University of Texas at San Antonio Health Science Center
Department of Ophthalmology, San Antonio, 1996. E. Joseph
Zayac (Principal Investigator), Paul D. Comeau O'hotographer),
Ray V. Reil (Photographer), Sandra J. Hunt (Technician).
Resource Centers
Chairman's Office, The Ohio State University College of Optometry, Columbus: Karla Zadnik (Chairman), Jodi M. Malone
(Study Coordinator).
CLEK Photography Reading Center, The Ohio State University College of Optometry, Columbus. Joseph T. Barr
(Director), Gilbert E. Pierce (Reader), Marjorie Jeandervin
(Reader), Roanne Flom (Reader), Gloria Scott-Tibbs (Study
Coordinator).
Coordinating Center, Department of Ophthalmology and
Visual Sciences and the Division of Biostatistics, Washington
University Medical School, St. Louis, Missouri: Mae O. Gordon
(Director), Ken Schechtman (Statistician), Brad S. Wilson (Statistical Data Analyst), Joel Achtenberg, (Senior Research Analyst), Teresa A. Roediger (Project Manager), Patricia A. Nugent
(Data Assistant), Michael Richman (Project Manager, 19941996).
Project Office, National Eye Institute, Rockville, Maryland,
Donald F. Everett.
Committees
Executive Committee: Karla Zadnik (Chairman), Joseph T.
Barr, Mae O. Gordon, Timothy B. Edrington, Donald F. Everett,
Timothy T. McMahon.
CLEK Topography Analysis Group: Loretta B. Szczotka
(Co-Chairman). Timothy T. McMahon (Co-Chairman), Robert J.
Anderson, Nina E. Friedman, Larry J. Davis, Thomas W. Raasch.
Data Monitoring and Oversight Committee: Gar)' R. Cutter
(Chairman), Robin L. Chalmers, Bruce A. Barron.
References
1. Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalrnol. 1984;
28:293-322.
2. Zadnik K, Gordon MO, Barr JT, Edrington TB, the CLEK Study
Group. Biomicroscopic signs and disease severity in keratoconus.
Cornea. 1996; 15:139-146.
3. Vogt A. Reflexlinien durch faltung spiegelnder grenzflachen im
bereiche von corneo, linsenkapsel und netzhaut. Graefes Arch
Ophthalmol. 1919:99:296-338.
2546
Zadnik
4. Harrison RJ, Klouda PT, Easty DL, Manku M, Charles J, Stewart CM.
Association between keratoconus and atopy. Br J Ophthalmol.
1989;73:8l6-822.
5. Swann PC, Waldron HE. Keratoconus: the clinical spectrum. J Am
Optom Assoc. 1986;57:204-209.
6. Karseras AG, Ruben M. Aetiology of keratoconus. Br J Ophthalmol. 1976;60:522-525.
7. Ridley F. Eye-rubbing and contact lenses. Br J Ophthalmol. 1961;
45:631.
8. Rabinowitz YS, Garbus J, McDonnell PJ. Computer-assisted corneal
topography in family members of patients with keratoconus. Arch
Ophthalmol. 1990; 108:365-371.
9. Redmond KB. The role of heredity in keratoconus. Trans Ophthalmol Soc Austr. 1968;27:52-54.
10. Forstot SL, Goldstein JH, Damiano RE, Dukes DK. Familial keratoconus. Ophthalmology. 1988;105:92-93.
11. Falls HF, Allen AW. Dominantly inherited keratoconus. Report of a
family./ Genet Hum. 1969;17:317-324.
12. Hammerstein W. Zur genetik des keratoconus. Graefes Arch Klin
Exp Ophthalmol. 1974;190:293-308.
13- Macsai MS, Varley GA, KrachmerJH. Development of keratoconus
after contact lens wear. Arch Ophthalmol. 1990; 108:435-538.
14. Smiddy WE, Hamburg TR, Kracher GP, Stark WJ. Keratoconus:
contact lens or keratoplasty? Ophthalmology. 1988;95:487-492.
15. Belin MW, Fowler WG, Chambers WA. Keratoconus: evaluation of
recent trends in the surgical and nonsurgical correction of keratoconus. Ophthalmology. 1988;95:335-337.
16. Fowler WC, Belin MW, Chambers WA. Contact lenses in the visual
correction of keratoconus. CLAOJ. 1988;l4:203-206.
17. Kennedy RH, Bourne WM, Dyer JA. A 48-year clinical and epidemiologic study of keratoconus. AmJ Ophthalmol. 1986;101:267273.
18. Tuft SJ, Moodaley LC, Gregory WM, Davison CR, Buckley RJ.
Prognostic factors for the progression of keratoconus. Ophthalmology. 1994; 101:439-447.
19. Lass JH, Lembach RG, Park SB, et al. Clinical management of
keratoconus: a multicenter analysis. Ophthalmology. 1990;97:
433-445.
Downloaded From: http://iovs.arvojournals.org/ on 05/05/2017
IOVS, December 1998, Vol. 39, No. 13
20. Eggink FAGJ, Pinckers AJLG, van Puyenbroek EP, Theeuwes A.
Keratoconus, a retrospective study. Contact Lens J. 1988; 16:204206.
21. Zadnik K, Mannis MJ, Johnson CA, Rich D. Rapid contrast sensitivity assessment in keratoconus. AmJ Optom Physiol Opt. 1987;
64:693-697.
22. De Cunha DA, Woodward EG. Measurement of corneal topography in keratoconus. Ophthalmic Physiol Opt. 1993; 13:377-382.
23. Maeda N, Klyce SD, Smolek MK, Thompson HW. Automated keratoconus screening with corneal topography analysis. Invest Ophthalmol VisSci. 1994;35:2749-2757.
24. Bailey IL, Lovie JE. New design principles for visual acuity letter
charts. AmJ Optom Physiol Opt. 1976;53:740-745.
25. Mandell RB. Keratoconus. In: Mandell RB, ed. Contact Lens Practice. Springfield, IL: Charles C. Thomas; 1988:732-751.
26. Edrington TB, Barr JT, Zadnik K, et al. Standardizedrigidcontact lens
fitting protocol for keratoconus. Optom Vis Sci. 1996;73:369-375.
27. Cohen J. Statistical Power Analysis for the Behavioral Sciences.
New York: Academic Press, 1977.
28. Ihalainen A. Clinical and epidemiological features of keratoconus.
Genetic and external factors in the pathogenesis of the disease.
Acta Ophthalmol. 1986; 178;(Suppl)178:l-64.
29. Kastl PR. A 20-year retrospective study of the use of contact lenses
in keratoconus. CLAOJ. 1987;13:102-104.
30. Crews MJ, Driebe WT, Stern GA. The clinical management of
keratoconus: a 6 year retrospective study. CLAOJ. 1994;20:194-197.
31. The Studies of Ocular Complication of AIDS Research Group, The
AIDS Clinical Trials Group. Assessment of cytomegalovirus retinitis. Clinical evaluation vs. centralized grading of fundus photographs. Arch Ophthalmol. 1996;114:791-805.
32. Chylack LTJ, Wolfe JK, Singer DM, et al. The Lens Opacities
Classification System III. Arch Ophthalmol. 1993;111:831-836.
33- Barbee RA, Halonen M, Lebowitz M, Burrows B. Distribution of IgE
in a community population sample: correlations with age, sex, and
allergen skin test reactivity./.<4//er<g>' Clin Immunol. 1981 ;68:106 111.
34. Fleiss JL. Statistical Methods for Rates and Proportions. New
York: John Wiley & Sons, 1981.